This observation supports the findings that propose a tumor suppressor role for SMYD4 in the development of breast cancer, at least partially, by inhibiting platelet-derived growth factor receptor α polypeptide (Pdgrf-α) [4]. Here, SMYD4 is linked to breast carcinoma.